Multiple Sclerosis: Current Status and Strategies for the Future
Janet E. Joy and Richard B. Johnston, Jr., Editors
2001. Committee on MS: Current Status and Strategies for the Future
Board on Neuroscience and Behavioral Health

An excellent, although quite technical site worth considering for those interested in the more advanced scientific and medical aspects of Multiple Sclerosis. This book is extremely up-to-date and written by the top researchers and clinicians in the field. The complete contents of this book are available online.

MS International Federation

MS Resource Centre (UK)

MS Society (Australia)

MS Society (Canada)

MS Society (UK)

World of Multiple Sclerosis
International Federation of MS Societies

Drug company sites

Drugs fully subsidised in New Zealand:

Maker: Schering AG (Europe) and Berlex (US)
Drug: Betaferon, known as Betaseron in the US (Interferon Beta 1b)
Help: MS Info Centre
Maker: Biogen Inc
Drug: Avonex (Interferon Beta 1a)

Not used in New Zealand:

Maker: Serono
Drug: Rebif (Interferon Beta 1a)
Help: MS Network
Maker: Teva Pharmaceutical Industries
Drug: Copaxone (glatiramer acetate)
Help: MS Watch

For a chart comparing these four drugs, visit multiplesclerosis.com

Want to recommend a website?

Email us the web address.

Material on this website may be reproduced, with credit to msakl.org.nz, except where other copyright is noted.